YS Biopharma Co., Ltd. (YS)

NASDAQ: YS · IEX Real-Time Price · USD

0.855

-0.081 (-8.65%)

At close: Apr 18, 2024, 4:00 PM

0.883

+0.028 (3.31%)

After-hours: Apr 18, 2024, 6:34 PM EDT

YS Biopharma Co. Cash Flow Statement

Financials in millions CNY. Fiscal year is April - March.

Millions CNY. Fiscal year is Apr - Mar.

Year	2022	2021	2020
Net Income	-421.46	-367.33	-225.05
Depreciation & Amortization	41.11	34.94	30.14
Share-Based Compensation	3.51	7.76	76.76
Other Operating Activities	56.38	20.42	-145.07
Operating Cash Flow	-182.47	-173.55	-246.61
Capital Expenditures	-52.69	-295.31	-104.24
Other Investing Activities	-4.29	-3.62	-
Investing Cash Flow	-56.98	-298.92	-104.24
Share Issuance / Repurchase	0	0	731
Debt Issued / Paid	100.88	364.56	8.26
Other Financing Activities	216.57	-	-
Financing Cash Flow	317.45	364.56	739.26
Exchange Rate Effect	21.3	-11.48	-0
Net Cash Flow	99.3	-119.39	388.41
Free Cash Flow	-235.16	-468.85	-350.85
Free Cash Flow Margin	-34.22%	-93.22%	-136.51%
Free Cash Flow Per Share	-2.53	-7.58	-5.67

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).